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influencethe resulting dose distribution. In the present work, we study 
the effect of different reconstruction parameters on dose distribution 
for both dose painting by contours (DPC) and dose painting by 
numbers (DPBN) techniques.  
Materials and Methods: 18FDG-PET/CT was performed for 8 advanced 
stage non-small cell lung cancer patients on a Siemens Biograph 40 
PET/CT-scanner.For each patient, 6 different PET reconstructions 
were applied; ordered subsets expectation maximization (OSEM) with 
21 subsets, using 2 (OSEM2i), 3 (OSEM3i)and 4 (OSEM4i) iterations. In 
addition, the data was reconstructed using theSiemens HD PET 
algorithm that corrects for the varying point spread function(PSF) 
inside the scanner, with 21 subsets, 2 (PSF2i), 3(PSF3i) and 4 
(PSF4i)iterations. Gaussian post filtering was 5 mm for all cases. A 
GTV was generated for each patient, encompassing the primary lung 
tumor including all voxels with an SUV > 2.0 in the standard OSEM2i 
reconstruction.  
For DPC, a boost volume was defined as the 50% of SUVmax for each 
reconstruction[1]. The boost volumes were assigned doses 
corresponding to an increase in mean GTV dose from 60 to 70 Gy. For 
each boost volume the quality factor (QF) [2] of the dose distribution 
was calculated with reference to the standard reconstruction as well 
as differences in boost volumes. For DPBN, a boost dose was 
distributed ranging from 60 to 130 Gy within the GTV assuming a 
linear relationship between FDG voxel intensity and prescribed dose 
distribution [2],using SUVmax as threshold for voxels receiving 
maximum dose. Dose volume histograms (DVH) were extracted for all 
reconstructions, as well as quality factors (QF) compared to the 
standard reconstruction OSEM2i.  
Results: For DPC, the mean boost volume was 32 ± 9 % and 31 ± 9 % of 
the GTV for OSEM2i and PSF2i, respectively. Correspondingly, the 
mean dose to the boost volume was 91 ± 10 Gyand 95 ± 13 Gy for 
OSEM2i and PSF2i. Considering the different reconstructions, the 
largest observed mean difference in boost volume was -11 ± 6 %, 
between OSEM4i and PSF2i. The mean difference in boost volume for 
OSEM2i and PSF2i was -9 ± 6%. The largest mean QF was 2.1 %, for 
PSF2i.  
For DPBN, for all patients except one, DVHs of the different 
reconstructions were approximately similar. The mean dose to the 
GTV was 81 ± 4 Gy and 80 ± 4 Gy for OSEM2i andPSF2i, respectively. 
The mean QF ofPSF2i relative to OSEM2i was 1.8 ± 0.8 %.  
Conclusions: PET reconstruction settings have an effect on PET-boost 
dose distributions, although the effect is small or moderate for most 
patients.  
[1] van Elmpt, W., De Ruysscher,D., van der Salm, A., et al. Radiother 
Oncol 2012; 104: 67-71. 
[2]Vanderstraten B,De Gersem W, Derie C, et al. Radiother Oncol 
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Purpose/Objective: Pareto front navigation, lexicographic ordering 
and other methods have been suggested to organize, guide and 
accelerate the dose optimization process. These methods are 
currently only feasible for the optimization of fluence weight profiles 
because the optimization of deliverable treatment plans adds greatly 
to their complexity. Thus, it is frequently not possible to maintain the 
carefully established balance between various treatment goals in leaf 
segmentation. We address the problem how a Pareto-optimal dose 
distribution can be preserved throughout the entire optimization, and 
replicated by a deliverable leaf sequence for VMAT or dMLC-IMRT, 
computed with the final dose algorithm. 
Materials and Methods: The method comprises 4 elements: 1) during 
the optimization of fluence profiles, a complimentary set of 
smoothing penalties and novel projection operators prevent 
undeliverable fluence distributions.This minimizes the quality loss due 
to leaf sequencing. 2) once the final dose distribution has been 
accepted, a multitude of features of the DVHs of targets and organs 
are captured in facsimile cost functions and their values recorded as 
reference. 3) after sequencing for VMAT or dMLC-IMRT and dose 
computation with the final algorithm, the leaf positions are iteratively 
adjusted in order to reproduce the previously determined facsimile 
cost function values. 4) as a final resort, the case that the Pareto-
optimum dose distribution cannot be replicated is detected 
automatically, and facsimile cost functions are relaxed in the order of 
the user´s preference, starting with the least significant. The user 
preference is recorded in the initial plan selection process. 
The method was implemented in the research version of a commercial 
planning system. Treatment plans were generated for 6 case classes 
comprising a minimum of 5 patients each. 
Results: Across all case classes, in 92% of cases the quality of the 
Pareto-optimum dose could be replicated or exceeded, but only if the 
following prerequisites were given: 1) the associated fluence profiles 
need to be subjected to rigorous smoothness and deliverability 
constraints so that the plan navigation is not performed on illusionary 
dose distributions. By the same token, the expert can also avoid 
making choices that cannot be realistically delivered. 2) the facsimile 
cost functions need to be organ- and target-specific, simple physical 
similarity measures either under-define (if too few are used) or over-
constrain (if too rigorous ones are used) the leaf sequence 
optimization. 3) for the leaf position optimization, the facsimile cost 
functions need to be treated as hard constraints, not as weighted 
objectives, to guarantee precise replication. 
Conclusions: The presented method replicates the quality of Pareto-
optimum dose distributions with deliverable plans, and thereby 
removes the need to consider highly complex delivery constraints 
during manual solution navigation.  
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Purpose/Objective: Aim of this study is to evaluate the performance 
of 5mm Millennium MLC and compare to a 2.5mm High Definition MLC 
for the treatment of Lung lesions using Volumetric Modulated Arc 
Therapy (VMAT) based Stereotactic Body Radiotherapy(SBRT). 
Materials and Methods: 10 Lung patients treated with SBRT at our 
institute were retrospectively planned with 5mm MMLC & 2.5mm 
HDMLC using VMAT technique. The gross tumor volume ranged from 
2.2 cm3 to 151 cm3. All these patients were treated with 5mm MMLC 
and hence 5mm MMLC plans were kept as reference. The reference 
plans were re-optimized and recomputed with identical planning 
parameters for 2.5 mm HDMLC system. Dose computation was 
performed using AcurosXB Advance dose calculation algorithm in 
Eclipse treatment planning system(Version 10) with tissue in-
homogeneity taken into account. Each plan was normalized such that 
95% of the planning target volume (PTV) receives 100% of the 
prescribed dose. Plan evaluation was performed using figures of 
merit for a rapid and objective assessment on the quality of two 
treatment plans for MMLC & HDMLC. For PTV conformity index (CI), 
Heterogeneity index (HI) were used to quantify the quality whereas 
for normal tissues, Gradient index (GI) defined as ratio of 50 % Isodose 
volume to the prescription Isodose volume & D25(25 % Isodose volume) 
were used. Planning objectives were based on RTOG 0915 guidelines. 
Results: Both the MLC meet the RTOG criteria for the CI and HI. As 
shown in the table-1 the CI range was from 1.07 (151 cm3) to 1.38 (2.2 
cm3) with median of 1.14 + 0.10 for HDMLC & 1.07 (151 cm3) - 
1.44(2.2 cm3) with median of 1.15+ 0.12 for MMLC. For normal tissues 
the GI ranges from 3.61 (151 cm3) to 6.14 (2.2 cm3)as compared to 
3.67 (151 cm3) to 7.22(2.2 cm3) for HDMLC & MMLC respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
